These findings suggest that VitD may reprogram cellular metabolism to a state less favorable for viral replication through downregulation of AKT, thereby reducing the glycolytic pathways essential for cellular activation and therefore, limiting HIV infection. This evidence concerns the gene AKT1 and HIV infectious disease.